| Drug Classes active in melanoma |
| Kinase inhibitors |
Immunomodulating antibodies |
Chemothepateutics Agents |
Vaccination |
| iBRAF |
ipilimumab |
DTIC |
MAGE A3 |
| iMEK |
Anti-PD1 |
TMZ |
PRAME |
| ic-Kit |
Anti-CD137 |
FTM |
NY-ISO1 |
| iPI3K |
Anti-CD40 |
CDDP |
|
| iAKT |
OX40 |
Paclitaxel |
IL2 + gp100 |
| imTOR |
Anti TGF b |
NAB-paclitaxel |
|
| |
L19IL2 |
|
|
| PARP inhibitors |
Immunomodulating small molecule |
Anti-angiogenic Agents |
Plasmid/ Oncolytic Virus |
| ABT-888 |
1 MT |
|
Allovectin-B7 |
| |
|
|
Onco-Vex |
| GSI |
HDAC |
Pro-apoptotic Drugs |
Adoptive Cell therapies |
|
